Hepatocellular Carcinoma
Your browser must have Javascript enabled in order for our dynamic player to be embedded. Please turn on Javascript in your browser preferences and then refresh this page.
Related Videos (5)
On Wednesday, March 17 at 7pm EST watch a presentation of research findings on the diagnosis, treatment and survival rates of Hepatocellular Carcinoma (HCC), from the Center for Liver Disease and Transplantation of NewYork-Presbyterian.
HCC, the most common form of liver cancer, is diagnosed in about 24,100 people each year. Watch this webcast to learn more about the latest advances in the diagnosis and treatment of liver cancer.
Participants
Featuring:
Jean Emond, MD
Vice Chair and Director of Transplantation
Abby Siegal, MD, MS
Medical Director, Hepatobiliary Oncology
Lorna Dove, MD, MPH
Associate Professor of Clinical Medicine
Benjamin Samstein, MD
Assitant Proffessor of Surgery Abdominal Organ Transplant and Hepatobiliary Surgery
Jonathan Susman, MD
Director of Interventional Oncology